Compositions and methods for treating disorders ameliorated by muscarinic receptor activation
US10933020B2 · kind B2 · utility
4Cited by
26References
46Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 27, 2019 |
| Grant date | Mar 2, 2021 |
| Priority date | — |
| Expiry date | Sep 27, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/454
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein is an oral pharmaceutical composition, comprising a plurality of xanomeline beads having a core comprising xanomeline or a salt thereof, and a plurality of trospium beads having a core comprising a salt of trospium.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.